Last Name

Jason Dare

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPediatrics, College of Medicine
DivisionPeds Rheumatology
Address ACH Sturgis Building
800 Marshall Street
Mail Slot # 512-02
Little Rock AR 72202
vCardDownload vCard

    Collapse Research Funds 
    Collapse principal investigator
    Funding Agency: Hoffman-LaRoche Pharmaceuticals - Title: Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients with Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis - Start Date: 2016-07-01

    Funding Agency: Pfizer - Title: A Long-term, Open-Label Follow-up Study of CP-600,550 For Treatment of Juvenile Idiopathic Arthritis (JIA) - Start Date: 2016-06-01

    Funding Agency: Genentech, Inc. - Title: A Phase 1b, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics and Safety of Tocilizumab Following Subcutaneous Administration to Patients with Systemic Juvenile Idiopathic Arthritis - Start Date: 2015-09-01

    Funding Agency: Pfizer - Title: Efficacy, Safety and Tolerability of Tofacitinib for Treatment of Polyarticular Course JIA in Children and Adolescent Subjects - Start Date: 2015-08-25

    Funding Agency: PPD Development, LP - Title: Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen for Subcutaneous Injection in Pediatric and Adolescent Patients with JIA - Start Date: 2014-04-04

    Funding Agency: Bristol Myers Squibb Pharmaceutical Research Institute - Title: A Phase 3 Multi-center, Open-Label Study to Evaluate PK, Efficacy and Safety of Abatacept Administered Subcutaneously in Children and Adolescents with Active Polyarticular JIA and Inadequate Response to biologic or non-biologic Disease Modifying Anti-Rheu - Start Date: 2013-06-03

    Funding Agency: Bristol Myers Squibb Pharmaceutical Research Institute - Title: An Observation Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis - Start Date: 2013-01-03

    Pass Through Agency: Cincinnati Children's Hospital Medical Center - Funding Agency: National Institutes of Health - Title: Gene Expression in Pediatric Arthritis - Start Date: 2012-09-01

    Pass Through Agency: Quintiles, Inc. - Funding Agency: AstraZeneca - Title: A 6 Month, Multicenter, Open-Label, Safety Study of VIMOVO in Adolescents Aged 12 - 16 Years Inclusive, with JIA - Start Date: 2012-05-01

    Pass Through Agency: PRA International - Funding Agency: UCB Pharma, Inc. - Title: A Multicenter, Open-Label Study to assess the Pharmacokinetics, safety, and efficacy of certolizumab pegol in children and adolescents with moderately to severely active polyarticular-course juvenile idiopathic arthritis - Start Date: 2012-01-15

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. N. Mohamed, J. Dare, K. Stine, P. Morris. Dermatomyositis Developing after Non-Hodgkin Lymphoma: Not a Paraneoplastic Process. Southern Society for Pediatric Research, Southern Regional Meeting. 2013.
    2. D. Josey Jr, M. Morris, J. Dare, B. Greenberg. A 16 Y.O. Male Presenting With Dyspnea And Fatigue. Am J Respir Crit Care Med. 2010; 181.
    3. Morris P, Dare J. Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J Pediatr Hematol Oncol. 2010 Apr; 32(3):189-91. PMID: 20057323.
      View in: PubMed
    4. Dare JA, Jahan S, Hiatt K, Torralba KD. Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis. Arthritis Rheum. 2009 May 15; 61(5):583-6. PMID: 19405014.
      View in: PubMed
    Dare's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description